CRSP
Crispr Therapeutics AG
55.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 54.9 | 56.7 | 230.6 | – | – | – | 29.2 | 20.7 | 15.4 | 15.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 156.2 | 117.2 | 62.7 | 65.1 | 26.3 | 52.9 | 74.1 | 59.6 | 473.2 | 888.1 | 1,892.1 | 11.1 | 12.7 | 8.9 | 15.6 | 75.8 | 14,936.0 | 11,967.5 | 14.5 | 9.5 | 6.4 | 5.3 | 347.4 | 382.8 | 7,312.6 | 35.5 | 26.1 | 21.2 | 13.8 | 20.6 | 22.8 | 19.9 | 91.9 | 79.0 | 113.3 | 157.2 | 1,342.5 | 1,114.3 | 392.8 | |
| – | 3.5 | 4.0 | 3.2 | 4.0 | 5.7 | 7.2 | 10.4 | 5.0 | 3.8 | 4.9 | 6.8 | 4.0 | 3.9 | 2.9 | 5.0 | 4.4 | 6.5 | 5.1 | 5.0 | 3.4 | 2.4 | 2.2 | 2.3 | 2.6 | 1.7 | 1.9 | 2.4 | 2.1 | 2.7 | 2.7 | 2.3 | 2.1 | 1.7 | 1.6 | 2.5 | 3.1 | 2.5 | 2.5 | 3.0 | |
| – | 106.7 | 86.9 | 42.5 | 48.5 | 21.5 | 45.4 | 66.7 | 46.6 | 338.3 | 696.7 | 1,572.6 | 8.2 | 9.4 | 5.9 | 12.4 | 62.5 | 13,326.4 | 10,509.3 | 12.6 | 8.4 | 5.4 | 4.6 | 311.4 | 346.6 | 6,863.0 | 32.2 | 23.6 | 18.2 | 12.7 | 18.1 | 20.5 | 18.8 | 84.3 | 73.1 | 108.5 | 149.9 | 1,246.6 | 1,158.4 | 416.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 53.1 | 61.6 | 1,247.6 | – | – | – | 24.8 | 17.6 | 12.2 | 12.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 129.8 | 73.4 | 65.0 | 99.6 | – | – | – | 25.9 | 18.4 | 12.7 | 11.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.2% | -8.6% | -12.1% | -11.5% | -7.2% | -3.6% | -3.0% | -4.0% | -6.7% | -6.5% | -5.3% | 0.8% | 1.4% | 1.5% | 1.0% | -2.8% | -2.4% | -3.4% | 3.9% | 5.4% | 7.9% | 8.6% | -10.9% | -10.0% | -16.7% | -10.6% | -8.2% | -8.1% | -5.3% | -3.0% | -2.7% | -4.8% | -4.3% | -10.5% | -7.7% | -5.1% | -7.3% | -8.8% | -9.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -970.8% | -717.9% | -590.4% | -485.1% | -493.2% | -70.3% | -87.9% | -123.4% | -197.2% | -3,541.9% | -5,779.4% | -10,248.5% | 27.4% | 39.8% | 31.0% | 24.1% | -201.6% | -37,027.4% | -30,357.9% | 77.8% | 83.2% | 77.6% | 76.5% | -1,536.3% | -1,688.2% | -25,186.7% | -21.5% | 22.1% | 31.1% | 64.8% | 48.3% | 24.3% | 28.2% | -240.6% | -252.7% | -229.8% | -356.8% | -6,490.3% | -5,360.9% | -1,534.4% | |
| -1,792.8% | -1,319.3% | -1,044.8% | -805.4% | -825.4% | -157.7% | -178.8% | -233.8% | -319.1% | -5,087.8% | -8,613.6% | -14,959.7% | -4.5% | 16.1% | 7.5% | -1.4% | -304.6% | -49,295.5% | -51,752.9% | 49.7% | 45.7% | 40.9% | 34.2% | -4,672.5% | -5,156.6% | -154,394.7% | -560.2% | -278.4% | -249.2% | -60.1% | -110.4% | -176.4% | -164.9% | -1,274.0% | -1,282.7% | -1,221.2% | -1,270.1% | -16,191.4% | -13,408.3% | -3,971.5% | |
| -1,714.6% | -449.3% | -490.3% | -406.6% | -466.6% | -166.7% | -189.6% | -245.6% | -331.8% | -5,281.1% | -8,839.0% | -15,136.6% | -5.3% | 23.1% | 15.7% | 6.8% | -273.1% | -48,520.9% | -51,347.8% | 49.6% | 45.7% | 41.3% | 34.1% | -4,670.1% | -5,108.0% | -149,122.7% | -522.7% | -244.5% | -208.0% | -41.5% | -80.3% | -132.2% | -118.8% | -1,000.1% | -1,042.8% | -1,252.2% | -1,297.1% | -16,569.8% | -13,856.5% | -3,368.7% | |
| 972.3% | -1,129.5% | -1,011.7% | -760.8% | -749.0% | -190.0% | -187.8% | -223.1% | -239.7% | -3,169.4% | -5,759.5% | -10,077.1% | 8.6% | 17.3% | 13.7% | 15.7% | -215.7% | -35,705.7% | -40,477.1% | 55.7% | 51.6% | 50.0% | 45.4% | -3,802.5% | -3,816.0% | -122,231.4% | -375.6% | -212.7% | -172.1% | -72.9% | -61.6% | -62.7% | -94.8% | -395.0% | -832.4% | -871.5% | -805.2% | -9,855.5% | -9,777.6% | -3,589.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | -10.0% | -16.8% | -20.9% | -28.7% | -36.4% | -25.9% | -34.4% | -28.1% | -42.1% | -48.7% | -54.5% | -1.9% | 7.1% | 5.1% | 2.1% | -15.7% | -21.0% | -21.7% | 17.2% | 16.4% | 15.7% | 13.9% | -30.3% | -34.8% | -34.7% | -28.3% | -22.9% | -20.5% | -8.2% | -10.4% | -13.4% | -12.4% | -19.0% | -21.1% | -27.3% | -25.5% | -30.3% | -31.3% | -25.8% | |
| -18.9% | -6.7% | -11.2% | -13.6% | -18.2% | -25.2% | -20.1% | -25.8% | -22.6% | -33.7% | -37.2% | -40.5% | -1.6% | 6.3% | 4.5% | 1.9% | -14.2% | -19.1% | -20.0% | 15.4% | 14.6% | 13.7% | 12.0% | -25.7% | -28.9% | -29.0% | -23.3% | -18.9% | -16.9% | -6.9% | -8.9% | -11.4% | -10.6% | -16.3% | -17.8% | -23.0% | -21.7% | -25.7% | -20.9% | -17.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -216 | -255 | -223 | -206 | -184 | -196 | -296 | -276 | -456 | -421 | -401 | -423 | -625 | -935 | -881 | -935 | -1,031 | -1,157 | -1,114 | -1,631 | -999 | -911 | -673 | -489 | -483 | -196 | -329 | -430 | -513 | -374 | -691 | -468 | -209 | -281 | -218 | -179 | -272 | -337 | 181 | 314 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -18.2 | -31.9 | -326.0 | – | – | – | -3.5 | -2.3 | -2.3 | -2.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -22.4% | 67.5% | 66.8% | 64.9% | 63.4% | 69.2% | 77.5% | 75.1% | 80.4% | 80.2% | 76.3% | 74.4% | 82.1% | 88.1% | 88.0% | 87.0% | 90.5% | 91.0% | 92.2% | 89.8% | 89.1% | 87.2% | 86.1% | 84.9% | 83.0% | 83.6% | 82.6% | 82.7% | 82.8% | 84.4% | 85.4% | 84.7% | 86.0% | 86.2% | 84.4% | 84.3% | 85.3% | 84.8% | 66.6% | 65.9% | |
| – | 0.3 | 0.3 | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.32 | -0.58 | -0.91 | -1.04 | -1.28 | -1.49 | -1.64 | -1.95 | -2.47 | -3.19 | -3.55 | -3.77 | -0.20 | 1.11 | 0.75 | 0.32 | -3.01 | -4.97 | -5.23 | 5.55 | 5.40 | 4.93 | 4.04 | -8.17 | -8.73 | -8.30 | -6.66 | -5.26 | -4.45 | -1.89 | -2.65 | -3.13 | -2.81 | -4.29 | -4.49 | -5.37 | -5.35 | -6.47 | -5.92 | -4.67 | |
| 0.08 | 0.13 | 0.19 | 0.26 | 0.27 | 0.89 | 0.86 | 0.79 | 0.75 | 0.06 | 0.04 | 0.02 | 3.69 | 4.81 | 4.76 | 4.71 | 1.10 | 0.01 | 0.01 | 11.20 | 11.81 | 11.92 | 11.85 | 0.17 | 0.17 | 0.01 | 1.27 | 2.15 | 2.14 | 4.55 | 3.31 | 2.37 | 2.37 | 0.43 | 0.43 | 0.43 | 0.41 | 0.04 | 0.04 | 0.14 | |
| -1.57 | 5.86 | 5.42 | 4.96 | 4.46 | 4.09 | 6.33 | 5.66 | 8.81 | 7.59 | 7.29 | 6.91 | 10.28 | 15.60 | 14.56 | 14.83 | 19.15 | 23.73 | 24.07 | 32.37 | 32.94 | 31.30 | 29.12 | 26.97 | 25.04 | 23.94 | 23.58 | 22.96 | 21.76 | 23.15 | 25.48 | 23.33 | 22.76 | 22.61 | 21.28 | 19.65 | 20.98 | 21.37 | 18.89 | 18.10 | |
| 0.75 | -1.47 | -1.88 | -1.94 | -2.06 | -1.70 | -1.62 | -1.77 | -1.79 | -1.92 | -2.32 | -2.51 | 0.32 | 0.83 | 0.65 | 0.74 | -2.38 | -3.66 | -4.12 | 6.24 | 6.10 | 5.97 | 5.37 | -6.65 | -6.52 | -6.80 | -4.79 | -4.57 | -3.68 | -3.32 | -2.04 | -1.48 | -2.24 | -1.69 | -3.58 | -3.74 | -3.32 | -3.85 | -4.18 | -4.98 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.